Thyrocare Technologies Other Announcement

Thyrocare Technologies Employee Stock Options

Thyrocare allotted 1,94,289 equity shares under its Employee Stock Option Scheme. The allotment lifts paid-up capital to Rs 159.36 crore.

Thyrocare Technologies Management Change

Thyrocare Technologies' Chief Scientific Officer, Dr. Preet Kaur, resigns effective November 6, 2026. The company is identifying a replacement and will disclose details later.

Thyrocare Technologies Other Announcement

Thyrocare disclosed NSE market purchases by an immediate relative and a KMP on 2 November 2026. Combined consideration is about Rs 0.11 Crore, with no promoter involved.

Value

₹0.11 Cr

Thyrocare Technologies Merger & Restructuring Worth ₹141.4 Cr

Thyrocare agreed to sell its entire stake in subsidiary Nueclear Healthcare to Trovera. The consideration is about Rs 141.40 Crore, including preference shares and cash.

Value

₹141.4 Cr

Thyrocare Technologies Annual General Meeting

Thyrocare Technologies reported postal ballot voting results approving the purchase of land and building from, and divestment of its entire shareholding in, Nueclear Healthcare Limited.

Thyrocare Technologies Earnings Call Transcript: Key Takeaways

Thyrocare reports robust 24% growth, pivoting from volume-led routine testing to specialized diagnostics under new management. High operational leverage is evident as PAT growth significantly outpaced revenue.

Call

Guides 20% growth

Aavas Financiers Other Announcement

AAVAS Financiers disclosed that Morningstar Sustainalytics improved its ESG risk score to 21.4 from 23.9. The rating was assigned voluntarily without company engagement.

Brijlaxmi Leasing & Finance Other Announcement

Brijlaxmi Leasing claims exemption from related party transaction disclosure under Regulation 23(9) for FY2025-26. Its capital and net worth fall within Regulation 15(2) limits.

Indrayani Biotech Other Announcement

Indrayani Biotech filed its quarterly shareholding pattern for 30 September 2026. Promoter group holds 32.89% of equity; this is routine compliance with no corporate event.

Interactive Financial Services Other Announcement

Interactive Financial Services filed its Reg 32 statement of deviation for its rights issue proceeds for the quarter ended 30 September 2026. The filing shows a variation approved in a 2025 EGM and zero utilisation during the quarter.

Shalibhadra Finance Other Announcement

Shalibhadra Finance Ltd filed its quarterly shareholding pattern as of 30 September 2026. The promoter and promoter group hold about 58.10% of 30,88,84,00 shares.

Jain Resource Recycling Other Announcement

Jain Resource Recycling filed the monitoring agency report on IPO proceeds for the quarter ended September 30, 2026. It flags a deviation from IPO objects.